Prevduo (neostigmine / glycopyrrolate) is a medication that's given intravenously (into the vein) to people in the hospital after undergoing surgery. Specifically, it's used for those who have received certain medications that temporarily paralyze their muscles during surgery. Prevduo is currently the only FDA-approved product containing two medications together: neostigmine and glycopyrrolate. Some side effects to look out for include drowsiness, blurred vision, and diarrhea.
Reverse the effects of certain muscle-paralyzing effects after surgery in adults and children age 2 years and older
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
Bouju, P., et al. (2017). Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: A prospective descriptive study. Annals of Intensive Care.
Clar, D. T., et al. (2023). Nondepolarizing neuromuscular blockers. StatPearls.
Endo International plc. (2023). Endo launches Prevduo™ (neostigmine methylsulfate and glycopyrrolate injection), the first and only FDA-approved neostigmine-glycopyrrolate combination pre-filled syringe. PRNewswire.
Gallanosa, A., et al. (2023). Glycopyrrolate. StatPearls.
Neely, G. A., et al. (2023). Neostigmine. StatPearls.
Par Pharmaceutical, Inc. (2023). Prevduo- neostigmine methylsulfate and glycopyrrolate injection [package insert]. DailyMed.
Sam, C., et al. (2023). Physiology, acetylecholine. StatPearls.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.